SkinBioTherapeutics plc (AIM: SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 17.60
-0.03 (-0.14%)
Jan 21, 2025, 2:29 PM GMT+1
SkinBioTherapeutics Revenue
In the fiscal year ending June 30, 2024, SkinBioTherapeutics had annual revenue of 1.21M GBP with 815.26% growth. SkinBioTherapeutics had revenue of 1.10M in the half year ending June 30, 2024, with 1,986.82% growth.
Revenue
1.21M
Revenue Growth
+815.26%
P/S Ratio
26.97
Revenue / Employee
80.58K
Employees
15
Market Cap
39.98M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 38.20B |
| GSK plc | 31.31B |
| Haleon | 11.24B |
| Smith & Nephew | 4.46B |
| ConvaTec Group | 1.74B |
| Hikma Pharmaceuticals | 2.39B |
| HUTCHMED (China) | 483.31M |
| Oxford Nanopore Technologies | 167.75M |